|
Sign In to gain access to subscriptions and/or personal tools.
|
Acute Hypoxia, Diabetes, and Neuroimmune Dysregulation: Converging Mechanisms in the Brain
Daniel R. Johnson,
Christina L. Sherry,
Jason M. York,
and
Gregory G. Freund, M.D.*
* To whom correspondence should be addressed. E-mail: freun{at}uiuc.edu.
 |
Abstract |
|---|
Acute hypoxia is experienced by a variety of individuals (neonates to the elderly) and in an assortment of conditions and diseases (terrorist bomb attack to decompensated heart failure). Increasingly, elaboration of inflammatory cytokines appears key to the brain-based response to hypoxia, as evidenced by the biobehaviors of malaise, fatigue, lethargy, and loss of interest in the physical and social environment. These sickness symptoms implicate hypoxia-dependent activation of the neuroimmune system as a key component of acute hypoxia. Type 2 diabetes (T2D) is associated with increased incidence, severity, and delayed recovery from hypoxic events. Why T2D negatively affects acute hypoxia is not well understood. Recent work, however, reveals that anti-inflammatory pathways tied to the interleukin (IL)-1 arm of the neuroimmune system may be critical. In this review, the authors examine the link between acute hypoxia, T2D, and neuroimmunity. DOI: 10.1177/1073858407309544
First published on November 13, 2007, doi:10.1177/1073858407309544
The Neuroscientist 2008;14:235.
A more recent version of this article appeared on June 1, 2008

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. L. Sherry, S. S. Kim, and G. G. Freund
Accelerated Recovery from Acute Hypoxia in Obese Mice Is Due to Obesity-Associated Up-Regulation of Interleukin-1 Receptor Antagonist
Endocrinology,
June 1, 2009;
150(6):
2660 - 2667.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|